RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets
RadNet (NASDAQ: RDNT) acquired the assets of Alpha RT to expand DeepHealth’s remote-imaging capabilities, combining Alpha RT’s staffing, training and AI safety monitoring with DeepHealth’s FDA-cleared TechLive™ remote scanning technology.
The combined portfolio supports remote MR, CT, PET and ultrasound scanning from an integrated command center, offers AI-driven MRI safety alerts, vendor-agnostic remote MRI technologist staffing, an MRI Tech Aide Certification program, and intelligent scheduling. Pilot metrics cited: a 0.06% recall rate on remote scans and a 42% reduction in MRI room closures.
RadNet (NASDAQ: RDNT) ha acquistato gli asset di Alpha RT per espandere le capacità di imaging remoto di DeepHealth, combinando lo staff, la formazione e il monitoraggio di sicurezza AI di Alpha RT con la tecnologia di scansione remota TechLive™ approvata dalla FDA di DeepHealth.
Il portafoglio combinato supporta la scansione remota MRI, CT, PET e ultrasuoni da un centro di comando integrato, offre avvisi di sicurezza MRI guidati dall'IA, staffing di tecnologi MRI remoti indipendente dal fornitore, un programma di certificazione MRI Tech Aide e una programmazione intelligente. Metriche pilota: un tasso di richiamo dello 0,06% sulle scansioni remote e una riduzione del 42% dei tempi di chiusura della sala MRI.
RadNet (NASDAQ: RDNT) adquirió los activos de Alpha RT para ampliar las capacidades de imágenes a distancia de DeepHealth, combinando el personal, la formación y la monitorización de seguridad de IA de Alpha RT con la tecnología de escaneo remoto TechLive™ de DeepHealth, aprobada por la FDA.
La cartera combinada admite el escaneo remoto de RM, TC, PET y ultrasonido desde un centro de mando integrado, ofrece alertas de seguridad de MRI impulsadas por IA, personal de technólogos de MRI remotos independiente del proveedor, un programa de certificación MRI Tech Aide y una programación inteligente. Métricas piloto: una tasa de recall del 0,06% en escaneos remotos y una reducción del 42% en cierres de salas de MRI.
RadNet (NASDAQ: RDNT)가 Alpha RT의 자산을 인수하여 DeepHealth의 원격 영상 기능을 확장했고, Alpha RT의 직원 구성, 교육 및 AI 안전 모니터링을 DeepHealth의 FDA 승인 TechLive™ 원격 스캐닝 기술과 결합합니다.
결합된 포트폴리오는 통합 지휘 센터에서 원격 MR, CT, PET 및 초음파 스캐닝을 지원하며, AI 기반 MRI 안전 경고, 공급업체에 구애받지 않는 원격 MRI 기술자 배치를 제공하고, MRI Tech Aide 인증 프로그램과 지능형 스케줄링을 제공합니다. 파일럿 지표: 원격 스캔에서 0.06%의 재촬영율 및 MRI 실의 종합 폐쇄를 42% 감소.
RadNet (NASDAQ : RDNT) a acquis les actifs d'Alpha RT pour étendre les capacités d'imagerie à distance de DeepHealth, en combinant le personnel, la formation et la surveillance de sécurité IA d'Alpha RT avec la technologie de balayage à distance TechLive™ approuvée par la FDA de DeepHealth.
Le portefeuille combiné prend en charge le balayage à distance MRI, CT, PET et échographie depuis un centre de commande intégré, propose des alertes de sécurité MRI pilotées par l'IA, un personnel distant de techniciens MRI sans dépendance vis-à-vis du fournisseur, un programme de certification MRI Tech Aide et une planification intelligente. Mesures pilotes: un taux de rappel à 0,06% sur les balayages distants et une réduction de 42% des fermetures de salle MRI.
RadNet (NASDAQ: RDNT) hat die Vermögenswerte von Alpha RT übernommen, um die Remote-Bilderfassungskapazitäten von DeepHealth zu erweitern, indem das Personal, Training und die KI-Sicherheitsüberwachung von Alpha RT mit der FDA-zertifizierten TechLive™ Remote-Scanning-Technologie von DeepHealth kombiniert werden.
Das kombinierte Portfolio unterstützt Remote-MRI, -CT, -PET und Ultraschall-Scans von einem integrierten Command-Center, bietet KI-gesteuerte MRI-Sicherheitswarnungen, herstellerunabhängige Remote-MRI-Technologen-Besetzung, ein MRI Tech Aide Certification-Programm und intelligente Terminplanung. Die Pilotmetriken nennen: eine 0,06% Recall-Rate bei Remote-Scans und eine 42% Reduktion der MRI-Raum-Schließungen.
استحوذت RadNet (بورصة ناسداك: RDNT) على أصول Alpha RT لتوسيع قدرات DeepHealth في التصوير عن بُعد، مع دمج موظفي Alpha RT وتدريبهم ومراقبة أمان الذكاء الاصطناعي مع تقنية DeepHealth للتصوير عن بُعد TechLive™ المعتمدة من FDA.
المجموعة المجمّعة تدعم المسح عن بُعد لـ MRI وCT وPET والأشعة فوق الصوتية من مركز قيادة متكامل، وتقدم تنبيهات أمان MRI قائمة على الذكاء الاصطناعي، وتوظيف تقنيي MRI عن بُعد مستقلين عن المورد، وبرنامج شهادة MRI Tech Aide، وجدولة ذكية. مقاييس التجربة: معدل الاستدعاء 0.06% للمسح عن بُعد وتقليل 42% في إغلاق غرف MRI.
- Acquisition of Alpha RT assets expands DeepHealth service offering
- TechLive™ integrates remote MR/CT/PET/ultrasound scanning from a command center
- 0.06% recall rate reported in TechLive™ pilot study
- 42% reduction in MRI room closures reported in TechLive™ pilot study
- Vendor-agnostic remote staffing provides on-demand access to MRI technologists
- Training and certification (MRI Tech Aide Certification) supports workforce development
- None.
Insights
Acquisition creates an end-to-end remote imaging stack that expands serviceable offerings and staffing reach.
RadNet combines DeepHealth’s FDA-cleared TechLive remote scanning platform with Alpha RT’s staffing, training and AI safety tools to offer a full-service remote-imaging solution to external customers and RadNet centers. The combined product set covers remote operation, real-time safety monitoring, vendor-agnostic technologist staffing, certification programs, and intelligent scheduling, which together enable a single vendor to sell both software-enabled workflows and human resources.
Key dependencies and risks include actual commercial uptake of remote-scanning services outside RadNet, integration of staffing and training into a unified go-to-market model, and preservation of the reported operational benefits during scale. The release cites a
Concrete items to watch in the near term are the commercial rollout cadence to external customers, contract terms for staffing services, and demonstrations at RSNA (
RadNet subsidiary DeepHealth to commercialize a robust end-to-end remote-imaging offering featuring both TechLive™ remote scanning technology and Alpha RT’s MRI staffing services and training programs
LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced it has acquired the assets of Alpha RT, a pioneer in remote MRI scanning solutions and services. The transaction creates a comprehensive remote-imaging portfolio, combining Alpha RT's staffing services and training programs with DeepHealth’s existing FDA-cleared TechLive™ remote scanning technology.
Following the acquisition, the remote-imaging portfolio includes:
- DeepHealth’s remote, multi-modality scanning technology: TechLive™ enables expert technologists to remotely perform or supervise MR, CT, PET and ultrasound scans simultaneously across multiple locations from an integrated command center. In a pilot study, TechLive™ was shown to achieve a
0.06% recall rate on remote scans without compromising quality1, while also delivering a42% reduction in MRI room closures to help keep facilities on schedule.2 - Alpha RT’s AI-powered safety monitoring: Real-time, AI-driven safety alerts for potentially unsafe materials or circumstances around the MRI suite, helping improve safety standards.
- Alpha RT’s remote MRI staffing services: Vendor-agnostic staffing services deliver on-demand access to highly skilled remote MRI technologists, supporting continuous operations tailored to operational needs.
- Alpha RT’s comprehensive training and certification: Specialized educational and training support, including an MRI Tech Aide Certification program, that strengthens workforce development and helps imaging centers deliver high-quality care.
- Alpha RT’s intelligent resource optimization: Workflow scheduling and dispatching capabilities that match the right technologist from a central resource pool to specific imaging needs, maximizing efficiency and expertise deployment.
“Rising patient demand for radiology services, coupled with a shortage of imaging technologists, is creating a significant challenge for imaging providers,” said Dr. Howard Berger, President and CEO, RadNet. “Through this acquisition, we are now able to deliver a comprehensive portfolio of remote-scanning solutions for both external DeepHealth customers and for the RadNet network of imaging centers—empowering each to keep pace with growing industry procedural volumes while maintaining the highest standard of patient care.”
“This strategic acquisition demonstrates the power of our test-and-scale approach,” said Kees Wesdorp, President and CEO of RadNet’s Digital Health Division. “We first validated TechLive™ and remote scanning within the RadNet network, where we continue to drive measurable operating improvements across several hundred imaging centers. This offering is now available to healthcare providers through DeepHealth. With AlphaRT, we can now deliver services to those imaging centers that need technologist staffing as well.”
DeepHealth will demonstrate its expanded remote imaging portfolio at the Radiological Society of North America 2025 Annual Meeting (RSNA) (Booth #1329), which will take place November 30–December 4 at McCormick Place in Chicago.
About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 405 owned and/or operated outpatient imaging centers. RadNet’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has about 11,000 team members. For more information, visit radnet.com.
About DeepHealth
DeepHealth is a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and serves as the umbrella brand for all companies within RadNet’s Digital Health Division. DeepHealth provides AI-powered health informatics with the aim of empowering breakthroughs in care through imaging. Building on the strengths of the companies it has integrated and is rebranding (e.g., eRAD Radiology Information and Image Management Systems and Picture Archiving and Communication System, Aidence lung AI, Kheiron, iCAD breast AI, Quantib prostate and brain AI, and See-Mode thyroid and breast AI), DeepHealth leverages advanced AI for operational efficiency and improved clinical outcomes in brain, breast, lung, prostate and thyroid health. At the heart of DeepHealth’s portfolio is a cloud-native operating system — DeepHealth OS — that unifies data across clinical and operational workflows and personalizes AI-powered workspaces for everyone in the radiology continuum. Thousands of radiologists at hundreds of imaging centers and radiology departments around the world use DeepHealth solutions to enable earlier, more reliable and more efficient disease detection, including in large-scale cancer screening programs. DeepHealth’s human-centered, intuitive technology aims to push the boundaries of what’s possible in healthcare. For more information, visit deephealth.com.
Forward-Looking Statements
This communication contains certain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can be identified by words such as: “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “outlook,” “plan,” “potential,” “possible,” “predict,” “project,” “seek, “should,” “target,” “will” or “would,” the negative of these words, and similar references to future periods. Examples of forward-looking statements include statements regarding TechLive bringing proven innovation to scale to benefit patients, providers and health systems alike and are qualified by the inherent risks and uncertainties surrounding future expectations generally, all of which are subject to change. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties, many of which are beyond RadNet’s control.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations and assumptions regarding the future of RadNet’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of RadNet’s control. RadNet’s actual results and financial condition may differ materially from those indicated in the forward-looking statements as a result of various factors. Neither RadNet nor its directors, executive officers, or advisors, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur, or if any of them do occur, what impact they will have on the business, results of operations or financial condition of RadNet. Should any risks and uncertainties develop into actual events, these developments could have a material adverse effect on RadNet’s business and the ability to realize the expected benefits of the acquisition. Risks and uncertainties that could cause results to differ from expectations include, but are not limited to: (1) the ability to recognize the anticipated benefits of the technology, and (2) the risk of legislative, regulatory, economic, competitive, and technological changes. The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included elsewhere. Additional information concerning risks, uncertainties and assumptions can be found in RadNet’s filings with the Securities and Exchange Commission (the “SEC”), including the risk factors discussed in RadNet’s most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and future filings with the SEC.
Forward-looking statements included herein are made only as of the date hereof and, except as required by applicable law, RadNet does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.
Contacts:
Investors:
Mark Stolper
Executive Vice President and Chief Financial Officer
310-445-2928
Media:
Jane Mazur
SVP, Corporate Communications
585-355-5978
jane.mazur@radnet.com
References
1) Data on file. Deployment at RadNet Northeast between June 2024 to June 2025.
2) Data on file. An internal review has shown a
FAQ
What did RadNet announce on November 5, 2025 regarding Alpha RT and RDNT?
How does TechLive™ remote scanning affect quality metrics for RDNT services?
What remote staffing capabilities did RadNet gain from the Alpha RT acquisition?
Will DeepHealth offer Alpha RT training programs under RadNet (RDNT)?
Which imaging modalities does DeepHealth’s integrated TechLive™ command center support for RDNT customers?
Where and when will DeepHealth demonstrate the expanded remote-imaging portfolio for RDNT?
